Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species
- 21 December 2002
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 45 (3) , 203-206
- https://doi.org/10.1016/s0732-8893(02)00525-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- In Vitro Activities of Terbinafine against Aspergillus Species in Comparison with Those of Itraconazole and Amphotericin BAntimicrobial Agents and Chemotherapy, 2001
- In Vitro Fungicidal Activities of Voriconazole, Itraconazole, and Amphotericin B against Opportunistic Moniliaceous and Dematiaceous FungiJournal of Clinical Microbiology, 2001
- In vitro Susceptibility of Candida dubliniensis to Current and New Antifungal AgentsChemotherapy, 2000
- Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998Antimicrobial Agents and Chemotherapy, 2000
- Timed-kill curves for Cryptococcus neoformans isolated from patients with AIDSMedical Mycology, 2000
- In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosisJournal of Antimicrobial Chemotherapy, 1998
- Comparison of In Vitro Antifungal Activities of Free and Liposome-Encapsulated Nystatin with Those of Four Amphotericin B FormulationsAntimicrobial Agents and Chemotherapy, 1998
- Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized MethodsAntimicrobial Agents and Chemotherapy, 1998
- Do In Vitro Susceptibility Data Predict the Microbiologic Response to Amphotericin B? Results of a Prospective Study of Patients withCandidaFungemiaThe Journal of Infectious Diseases, 1998
- Amphotericin B Serum Concentrations During Therapy 1Applied Microbiology, 1970